Inverness Counsel’s Thermo Fisher Scientific TMO Stock Holding History

Inverness Counsel’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$14.4M	Buy	28,469 +202	+0.7%	+$113K	0.8%	37
2022 Q2	$15.4M	Sell	28,267 -5,927	-17%	-$3.26M	0.86%	33
2022 Q1	$20.2M	Sell	34,194 -267	-0.8%	-$153K	0.9%	32
2021 Q4	$23M	Buy	34,461 +737	+2%	+$460K	0.85%	33
2021 Q3	$19.3M	Buy	33,724 +289	+0.9%	+$159K	0.71%	37
2021 Q2	$16.9M	Sell	33,435 -32,304	-49%	-$15.2M	0.61%	42
2021 Q1	$30M	Buy	65,739 +10,348	+19%	+$4.94M	1.24%	29
2020 Q4	$25.8M	Buy	55,391 +16,344	+42%	+$7.66M	1.05%	33
2020 Q3	$17.2M	Sell	39,047 -18,935	-33%	-$7.82M	0.77%	35
2020 Q2	$21M	Sell	57,982 -4,274	-7%	-$1.43M	1.05%	31
2020 Q1	$17.7M	Sell	62,256 -109,103	-64%	-$34.4M	1.11%	30
2019 Q4	$55.7M	Buy	171,359 +62,165	+57%	+$18.8M	2.63%	9
2019 Q3	$31.8M	Buy	109,194 +80,639	+282%	+$23.1M	1.65%	23
2019 Q2	$8.39M	Sell	28,555 -132,814	-82%	-$36.6M	0.43%	47
2019 Q1	$44.2M	Buy	161,369 +25,089	+18%	+$6.24M	2.41%	12
2018 Q4	$30.5M	Buy	136,280 +82,096	+152%	+$19.3M	2.04%	17
2018 Q3	$13.2M	Buy	+54,184	New	+$12.5M	0.7%	38

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Inverness Counsel's TMO Position: Q3 2022 in Review

Inverness Counsel increased its Thermo Fisher Scientific (TMO) stake by 0.71% in Q3 2022, buying an estimated $113K and bringing the position to 28,469 shares worth $14.4M. The position accounts for 0.8% of the portfolio, ranked #37.

Inverness Counsel first reported a position in TMO in Q3 2018 and has held it in 17 quarters since. The position peaked at $55.7M in Q4 2019. 2,267 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

Inverness Counsel held 28,469 shares of Thermo Fisher Scientific worth $14.4M as of Q3 2022.
Inverness Counsel bought 202 Thermo Fisher Scientific shares in Q3 2022, an estimated $113K.
Thermo Fisher Scientific made up 0.8% of Inverness Counsel's portfolio in Q3 2022, its #37 holding.
Inverness Counsel first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 17 quarters since.
Inverness Counsel's Thermo Fisher Scientific position peaked at $55.7M in Q4 2019.
2,267 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Inverness Counsel's 13F filing for Q3 2022, filed 26 Oct 2022.